ES2729035T3 - Microesferas cristalinas y el proceso para fabricarlas - Google Patents
Microesferas cristalinas y el proceso para fabricarlas Download PDFInfo
- Publication number
- ES2729035T3 ES2729035T3 ES13781897T ES13781897T ES2729035T3 ES 2729035 T3 ES2729035 T3 ES 2729035T3 ES 13781897 T ES13781897 T ES 13781897T ES 13781897 T ES13781897 T ES 13781897T ES 2729035 T3 ES2729035 T3 ES 2729035T3
- Authority
- ES
- Spain
- Prior art keywords
- microspheres
- composition comprises
- microsphere
- approximately
- less
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000004005 microsphere Substances 0.000 title claims abstract description 978
- 238000000034 method Methods 0.000 title description 43
- 230000008569 process Effects 0.000 title description 26
- 238000004519 manufacturing process Methods 0.000 title description 18
- 239000000203 mixture Substances 0.000 claims abstract description 297
- 229920005862 polyol Polymers 0.000 claims abstract description 19
- 150000003077 polyols Chemical class 0.000 claims abstract description 18
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 116
- 239000000594 mannitol Substances 0.000 claims description 111
- 229930195725 Mannitol Natural products 0.000 claims description 107
- 235000010355 mannitol Nutrition 0.000 claims description 107
- 239000002245 particle Substances 0.000 claims description 100
- 239000000463 material Substances 0.000 claims description 73
- 239000008186 active pharmaceutical agent Substances 0.000 claims description 49
- 238000009826 distribution Methods 0.000 claims description 33
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 10
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 10
- 239000000600 sorbitol Substances 0.000 claims description 10
- 239000008194 pharmaceutical composition Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 238000000576 coating method Methods 0.000 description 89
- 239000011248 coating agent Substances 0.000 description 76
- 239000011049 pearl Substances 0.000 description 67
- 239000011324 bead Substances 0.000 description 51
- 238000001179 sorption measurement Methods 0.000 description 38
- 239000011162 core material Substances 0.000 description 35
- 239000003826 tablet Substances 0.000 description 26
- 239000000843 powder Substances 0.000 description 23
- 239000000155 melt Substances 0.000 description 20
- 239000007921 spray Substances 0.000 description 20
- 239000010408 film Substances 0.000 description 19
- 239000007788 liquid Substances 0.000 description 17
- 239000010410 layer Substances 0.000 description 16
- 239000007787 solid Substances 0.000 description 16
- 239000005357 flat glass Substances 0.000 description 15
- 238000001878 scanning electron micrograph Methods 0.000 description 14
- 230000015572 biosynthetic process Effects 0.000 description 13
- 238000005755 formation reaction Methods 0.000 description 13
- 239000003795 chemical substances by application Substances 0.000 description 12
- 239000006185 dispersion Substances 0.000 description 12
- 239000011521 glass Substances 0.000 description 12
- 239000011148 porous material Substances 0.000 description 12
- 238000000926 separation method Methods 0.000 description 12
- 238000013517 stratification Methods 0.000 description 12
- 239000004386 Erythritol Substances 0.000 description 11
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 11
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 11
- 235000019414 erythritol Nutrition 0.000 description 11
- 229940009714 erythritol Drugs 0.000 description 11
- 239000000546 pharmaceutical excipient Substances 0.000 description 11
- 229920002472 Starch Polymers 0.000 description 10
- 239000004480 active ingredient Substances 0.000 description 10
- 238000001816 cooling Methods 0.000 description 10
- 239000008187 granular material Substances 0.000 description 10
- 230000033001 locomotion Effects 0.000 description 10
- 238000002844 melting Methods 0.000 description 10
- 230000008018 melting Effects 0.000 description 10
- 235000019698 starch Nutrition 0.000 description 10
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 9
- 238000007906 compression Methods 0.000 description 9
- 239000013078 crystal Substances 0.000 description 9
- 239000012530 fluid Substances 0.000 description 9
- 230000004927 fusion Effects 0.000 description 9
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 9
- 238000004626 scanning electron microscopy Methods 0.000 description 9
- 239000008107 starch Substances 0.000 description 9
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 8
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 8
- 239000011230 binding agent Substances 0.000 description 8
- 230000006835 compression Effects 0.000 description 8
- 238000009472 formulation Methods 0.000 description 8
- 239000000905 isomalt Substances 0.000 description 8
- 235000010439 isomalt Nutrition 0.000 description 8
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 8
- 239000000845 maltitol Substances 0.000 description 8
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 8
- 235000010449 maltitol Nutrition 0.000 description 8
- 229940035436 maltitol Drugs 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 8
- 230000008520 organization Effects 0.000 description 8
- 235000000346 sugar Nutrition 0.000 description 8
- 239000000811 xylitol Substances 0.000 description 8
- 235000010447 xylitol Nutrition 0.000 description 8
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 8
- 229960002675 xylitol Drugs 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- 238000005469 granulation Methods 0.000 description 7
- 230000003179 granulation Effects 0.000 description 7
- 238000005192 partition Methods 0.000 description 7
- 238000000113 differential scanning calorimetry Methods 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 239000008108 microcrystalline cellulose Substances 0.000 description 6
- 229940016286 microcrystalline cellulose Drugs 0.000 description 6
- 239000003981 vehicle Substances 0.000 description 6
- 239000002775 capsule Substances 0.000 description 5
- 239000007910 chewable tablet Substances 0.000 description 5
- 238000001000 micrograph Methods 0.000 description 5
- 238000005204 segregation Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 238000005054 agglomeration Methods 0.000 description 4
- 230000002776 aggregation Effects 0.000 description 4
- 235000010980 cellulose Nutrition 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 239000011247 coating layer Substances 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 4
- 238000010191 image analysis Methods 0.000 description 4
- 239000002198 insoluble material Substances 0.000 description 4
- 238000011068 loading method Methods 0.000 description 4
- 239000004570 mortar (masonry) Substances 0.000 description 4
- 239000011164 primary particle Substances 0.000 description 4
- 238000005096 rolling process Methods 0.000 description 4
- 238000005507 spraying Methods 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- 150000008163 sugars Chemical class 0.000 description 4
- 239000000654 additive Substances 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 239000007884 disintegrant Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- -1 fatty acid esters Chemical class 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000001307 helium Substances 0.000 description 3
- 229910052734 helium Inorganic materials 0.000 description 3
- 238000007373 indentation Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000000314 lubricant Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000008185 minitablet Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000012768 molten material Substances 0.000 description 3
- 238000013268 sustained release Methods 0.000 description 3
- 239000012730 sustained-release form Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 244000241235 Citrullus lanatus Species 0.000 description 2
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 2
- 244000024675 Eruca sativa Species 0.000 description 2
- 235000014755 Eruca sativa Nutrition 0.000 description 2
- 238000001159 Fisher's combined probability test Methods 0.000 description 2
- 239000002202 Polyethylene glycol Chemical class 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 239000008135 aqueous vehicle Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 239000007771 core particle Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000194 fatty acid Chemical class 0.000 description 2
- 229930195729 fatty acid Chemical class 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000007888 film coating Substances 0.000 description 2
- 238000009501 film coating Methods 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000005243 fluidization Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000003979 granulating agent Substances 0.000 description 2
- 235000015220 hamburgers Nutrition 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical class CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 210000003041 ligament Anatomy 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- 229940034008 mannitol / sorbitol Drugs 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 230000006911 nucleation Effects 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 238000003921 particle size analysis Methods 0.000 description 2
- 239000011236 particulate material Substances 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 239000004014 plasticizer Substances 0.000 description 2
- 229920001223 polyethylene glycol Chemical class 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000001812 pycnometry Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000004904 shortening Methods 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- ZSDSQXJSNMTJDA-UHFFFAOYSA-N trifluralin Chemical compound CCCN(CCC)C1=C([N+]([O-])=O)C=C(C(F)(F)F)C=C1[N+]([O-])=O ZSDSQXJSNMTJDA-UHFFFAOYSA-N 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 235000015866 Citrullus vulgaris var fistulosus Nutrition 0.000 description 1
- 244000016285 Citrullus vulgaris var. fistulosus Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- CXOFVDLJLONNDW-UHFFFAOYSA-N Phenytoin Chemical compound N1C(=O)NC(=O)C1(C=1C=CC=CC=1)C1=CC=CC=C1 CXOFVDLJLONNDW-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 230000000181 anti-adherent effect Effects 0.000 description 1
- 239000003911 antiadherent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 description 1
- 229960000623 carbamazepine Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940068682 chewable tablet Drugs 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 238000002288 cocrystallisation Methods 0.000 description 1
- 239000012612 commercial material Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 239000012050 conventional carrier Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000005485 electric heating Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000005454 flavour additive Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 230000007773 growth pattern Effects 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 238000012792 lyophilization process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002687 nonaqueous vehicle Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical class CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Chemical class CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000002357 osmotic agent Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 229960002036 phenytoin Drugs 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229940069328 povidone Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000008117 stearic acid Chemical class 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 239000007916 tablet composition Substances 0.000 description 1
- 238000009475 tablet pressing Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 238000002076 thermal analysis method Methods 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 239000001993 wax Chemical class 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261638073P | 2012-04-25 | 2012-04-25 | |
| US201361783603P | 2013-03-14 | 2013-03-14 | |
| PCT/US2013/038257 WO2013163453A1 (en) | 2012-04-25 | 2013-04-25 | Crystalline microspheres and the process for manufacturing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2729035T3 true ES2729035T3 (es) | 2019-10-29 |
Family
ID=49483900
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES13781897T Active ES2729035T3 (es) | 2012-04-25 | 2013-04-25 | Microesferas cristalinas y el proceso para fabricarlas |
Country Status (9)
| Country | Link |
|---|---|
| US (5) | US20150140097A1 (enExample) |
| EP (2) | EP3583935A1 (enExample) |
| JP (2) | JP6577865B2 (enExample) |
| BR (1) | BR112014026351B1 (enExample) |
| CA (1) | CA2871429C (enExample) |
| ES (1) | ES2729035T3 (enExample) |
| IN (1) | IN2014DN09416A (enExample) |
| MX (1) | MX359554B (enExample) |
| WO (1) | WO2013163453A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL219362A (en) | 2012-04-23 | 2017-04-30 | Verint Systems Ltd | A system and method for predicting threatened points of interest |
| US20150140097A1 (en) | 2012-04-25 | 2015-05-21 | Spi Pharma, Inc. | Crystalline microspheres and the process for manufacturing the same |
| US10560842B2 (en) | 2015-01-28 | 2020-02-11 | Verint Systems Ltd. | System and method for combined network-side and off-air monitoring of wireless networks |
| IL242354B (en) | 2015-10-29 | 2019-09-26 | Verint Systems Ltd | System and method for identifying genuine base stations that serve rogue base stations |
| IL245299B (en) | 2016-04-25 | 2021-05-31 | Verint Systems Ltd | A system and method for decoding communication transmitted in a wireless local communication network |
| US10639312B1 (en) * | 2019-12-06 | 2020-05-05 | Edenbridge Pharmaceuticals, LLC | Finished pharmaceutical dosage form of a methenamine salt such as methenamine mandelate |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4820627A (en) * | 1986-03-24 | 1989-04-11 | Em Diagnostic Systems, Inc. | Method of preparing particles suitable for tabletting into diagnostic reagents |
| JPH0192403A (ja) | 1987-09-30 | 1989-04-11 | Aprica Kassai Inc | 使い捨ておむつ |
| FR2670398B1 (fr) * | 1990-12-14 | 1995-02-17 | Roquette Freres | Composition pulverulente directement compressible et procede d'obtention. |
| US5573783A (en) | 1995-02-13 | 1996-11-12 | Nano Systems L.L.C. | Redispersible nanoparticulate film matrices with protective overcoats |
| US6548095B1 (en) | 1996-08-24 | 2003-04-15 | Südzucker Aktiengesellschaft | Sugar-free compressed products |
| US6235947B1 (en) * | 1997-04-14 | 2001-05-22 | Takeda Chemical Industries, Ltd. | D-mannitol and its preparation |
| US5780055A (en) | 1996-09-06 | 1998-07-14 | University Of Maryland, Baltimore | Cushioning beads and tablet comprising the same capable of forming a suspension |
| JPH1092403A (ja) | 1996-09-17 | 1998-04-10 | Sanyo Electric Co Ltd | 電池収納機構及びこれを具えた電子機器 |
| JP3447042B2 (ja) * | 1997-07-23 | 2003-09-16 | フロイント産業株式会社 | 単一物質球形粒の製造方法 |
| GB9716432D0 (en) * | 1997-08-05 | 1997-10-08 | Cerestar Holding Bv | Tableting of erythritol |
| JP2000128774A (ja) | 1998-10-26 | 2000-05-09 | Tanabe Seiyaku Co Ltd | 薬物を含有する球形微粒子の製法 |
| US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| WO2002035991A2 (en) * | 2000-10-30 | 2002-05-10 | The Board Of Regents, The University Of Texas System | Spherical particles produced by a hot-melt extrusion/spheronization process |
| AU2002346472A1 (en) * | 2001-11-20 | 2003-06-10 | Advanced Inhalation Research, Inc. | Particulate compositions for improving solubility of poorly soluble agents |
| US7118765B2 (en) | 2001-12-17 | 2006-10-10 | Spi Pharma, Inc. | Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms |
| KR20040098023A (ko) * | 2002-03-26 | 2004-11-18 | 테바 파마슈티컬 인더스트리즈 리미티드 | 약물 미세입자 |
| GB0228826D0 (en) * | 2002-12-11 | 2003-01-15 | Okpala Joseph | Hair technology in creating particles with improved delivery capabilities |
| CA2514932A1 (en) * | 2003-01-29 | 2004-08-12 | Spi Polyols, Inc. | Compositions of polyol granules and processes of manufacture |
| WO2005009375A2 (en) | 2003-07-22 | 2005-02-03 | Baxter International Inc. | Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof |
| US20070092562A1 (en) | 2003-10-28 | 2007-04-26 | Spi Pharma, Inc. | Product and process for increasing compactibility of carbohydrates |
| EP1677736A4 (en) * | 2003-10-28 | 2007-09-12 | Spi Pharma Inc | PRODUCT AND PROCESS FOR INCREASING COMPACTION ABILITY FOR CARBOHYDRATES |
| EP1689368B1 (en) | 2003-12-04 | 2016-09-28 | Bend Research, Inc | Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions |
| MXPA06012992A (es) * | 2004-05-12 | 2007-02-12 | Baxter Int | Microesferas que comprenden proteina y que muestran inyectabilidad en altas concentraciones de este agente. |
| WO2006058250A2 (en) | 2004-11-24 | 2006-06-01 | Spi Pharma, Inc. | Orally disintegrating compositions |
| WO2006109653A1 (ja) | 2005-04-06 | 2006-10-19 | Sanyo Chemical Industries, Ltd. | 樹脂粒子および樹脂分散体 |
| JP2007217651A (ja) * | 2006-02-20 | 2007-08-30 | Daicel Chem Ind Ltd | 環状ポリオレフィン系樹脂の球状粒子およびその製造方法 |
| CA2659918C (en) * | 2006-08-01 | 2013-02-05 | The Procter & Gamble Company | Benefit agent containing delivery particle |
| EP2091519B1 (en) | 2006-11-30 | 2015-06-24 | Bend Research, Inc | Multiparticulates of spray-coated drug and polymer on a meltable core |
| WO2008094877A2 (en) | 2007-01-30 | 2008-08-07 | Drugtech Corporation | Compositions for oral delivery of pharmaceuticals |
| BRPI0810978B1 (pt) | 2007-05-28 | 2021-05-25 | Mitsubishi Shoji Foodtech Co., Ltd | Partícula esférica de manitol cristalino |
| JP5258268B2 (ja) | 2007-11-19 | 2013-08-07 | フロイント産業株式会社 | 球形粒の製造方法 |
| EP2327424A4 (en) * | 2008-08-18 | 2014-10-01 | Mitsubishi Shoji Foodtech Co Ltd | NEW AUXILIARY FOR MANNITOL TABLETTING |
| AU2010223105B2 (en) | 2009-03-09 | 2016-05-12 | Spi Pharma, Inc. | Highly compactable and durable direct compression excipients and excipient systems |
| EA027618B1 (ru) * | 2009-05-08 | 2017-08-31 | Эмпликюре Аб | Композиция для непрерывной доставки лекарственного средства, содержащая геополимерное связующее |
| JP2011157348A (ja) * | 2010-01-05 | 2011-08-18 | Fuji Chem Ind Co Ltd | 崩壊性高強度球状粒子組成物 |
| DE102010045479A1 (de) | 2010-09-16 | 2014-10-30 | Brace Capital Gmbh | Verfahren zur Mikroverkapselung, Herstellung von festen Formen mehrphasiger mischbarer und nichtmischbarer Materialien und Methode zur Herstellung vorgenannter Systeme |
| JP6173912B2 (ja) | 2010-09-20 | 2017-08-02 | エスピーアイ ファーマ，インコーポレイテッド | マイクロカプセル化プロセスおよび製品 |
| US20150140097A1 (en) * | 2012-04-25 | 2015-05-21 | Spi Pharma, Inc. | Crystalline microspheres and the process for manufacturing the same |
-
2013
- 2013-04-25 US US14/397,011 patent/US20150140097A1/en not_active Abandoned
- 2013-04-25 EP EP19163519.2A patent/EP3583935A1/en not_active Withdrawn
- 2013-04-25 US US13/870,556 patent/US9089487B2/en active Active
- 2013-04-25 MX MX2014012805A patent/MX359554B/es active IP Right Grant
- 2013-04-25 IN IN9416DEN2014 patent/IN2014DN09416A/en unknown
- 2013-04-25 CA CA2871429A patent/CA2871429C/en active Active
- 2013-04-25 EP EP13781897.7A patent/EP2841057B1/en active Active
- 2013-04-25 BR BR112014026351-5A patent/BR112014026351B1/pt active IP Right Grant
- 2013-04-25 ES ES13781897T patent/ES2729035T3/es active Active
- 2013-04-25 WO PCT/US2013/038257 patent/WO2013163453A1/en not_active Ceased
- 2013-04-25 JP JP2015509147A patent/JP6577865B2/ja active Active
-
2015
- 2015-07-27 US US14/809,362 patent/US10245232B2/en active Active
-
2019
- 2019-03-11 JP JP2019043904A patent/JP2019112438A/ja active Pending
- 2019-04-01 US US16/371,262 patent/US11278496B2/en active Active
-
2022
- 2022-02-08 US US17/666,608 patent/US12233163B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2871429C (en) | 2018-07-31 |
| BR112014026351B1 (pt) | 2022-09-27 |
| US11278496B2 (en) | 2022-03-22 |
| EP3583935A1 (en) | 2019-12-25 |
| US20160015640A1 (en) | 2016-01-21 |
| EP2841057B1 (en) | 2019-03-20 |
| WO2013163453A1 (en) | 2013-10-31 |
| BR112014026351A2 (pt) | 2017-06-27 |
| MX359554B (es) | 2018-10-02 |
| US10245232B2 (en) | 2019-04-02 |
| US20150140097A1 (en) | 2015-05-21 |
| US12233163B2 (en) | 2025-02-25 |
| EP2841057A1 (en) | 2015-03-04 |
| IN2014DN09416A (enExample) | 2015-07-17 |
| CA2871429A1 (en) | 2013-10-31 |
| US9089487B2 (en) | 2015-07-28 |
| JP2015514809A (ja) | 2015-05-21 |
| JP6577865B2 (ja) | 2019-09-18 |
| JP2019112438A (ja) | 2019-07-11 |
| US20140099372A1 (en) | 2014-04-10 |
| EP2841057A4 (en) | 2015-09-16 |
| US20220151932A1 (en) | 2022-05-19 |
| MX2014012805A (es) | 2015-01-22 |
| US20190224126A1 (en) | 2019-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12233163B2 (en) | Crystalline microspheres and the process of manufacturing the same | |
| ES2761407T3 (es) | Forma de dosificación rápidamente dispersable de topiramato | |
| ES2688889T3 (es) | Proceso de mezcla sin disolvente para el recubrimiento de ingredientes farmacéuticos | |
| US20150366802A1 (en) | Rapidly Dispersible Dosage Form of Oxcarbazepine | |
| Li et al. | A novel gastro-floating multiparticulate system for dipyridamole (DIP) based on a porous and low-density matrix core: In vitro and in vivo evaluation | |
| MXPA06011765A (es) | Farmacos de sabor enmascarado en multiparticulados que se rompen. | |
| ES2266496T3 (es) | Procedimiento para la preparacion de comprimidos a partir de sustancias farmaceuticamente activas que presentan propiedades de compresion desfavorables con un liquido de granulacion que comprende la celulosa microcristalina. | |
| JP2025527357A (ja) | 味マスキングマイクロスフェア及びその製造プロセスと使用 | |
| Sinha et al. | Extrusion-spheronization: process variables and characterization | |
| Wen | Adsorption at solid surfaces: pharmaceutical applications | |
| CN114028577A (zh) | 一种二氧化硅丸芯及其制备方法 | |
| Dahiya et al. | Gastroretentive dosage forms: an approach to oral controlled drug delivery systems | |
| HK1214768B (en) | Rapidly dispersible dosage form of topiramate | |
| HK1214173B (en) | Rapidly dispersible dosage form of oxcarbazepine |